Use of gm-csf as a vaccine adjuvant

Details Use of gm-csf as a vaccine adjuvant Use of gm-csf as a vaccine adjuvant

A - Human Necessities

61

K

A61K 39/39 (2006.01) A61K 38/19 (2006.01) A61K 39/145 (2006.01) A61K 39/29 (2006.01)

Patent

CA 2139756

The present invention is a method for enhancing the immune response of a mammal to a vaccine comprising administering to such a mammal an effective amount of GM-CSF in conjunction with a vaccine. The present invention further provides for a pharmaceutical composition comprising an effective amount of GM-CSF, a natural, synthetic or recombinant antigen and a pharmaceutically acceptable carrier.

Affiliated with

Also associated with

Rating

Use of gm-csf as a vaccine adjuvant does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of gm-csf as a vaccine adjuvant, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of gm-csf as a vaccine adjuvant will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1810184